University of Arkansas   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Fayetteville AR United States (1871)

Organization Overview

First Clinical Trial
2001
NCT00569855
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Allergy/Immunology Department, Arkansas Children's Hospital | Arkansas Cancer Research Center | Arkansas Children's Hospital | Arkansas Childrens Hospital | Arkansas Children's Hospital and University of Arkansas for Medical Sciences | Arkansas Children's Hospital at the University of Arkansas for Medical Sciences | Arkansas Children's Hospital Research Institute | Arkansas Children's Nutrition Center | Arkansas Children's Research Institute | Arkansas Heart Hospital | UAMS | UAMS Center for Addiction Research | UAMS Myeloma Institute for Research and Therapy | UAMS Myeloma Institute for Research & Therapy | UAMS professor | Universitiy of Arkansas for Medical Sciences | University of Arkanas for Medical Sciences website | University of Arkansas | University of Arkansas, Fayetteville | University of Arkansas for Medical Science-Myeloma Institute | University of Arkansas for Medical Sciences / Arkansas Children's Hospital | University of Arkansas for Medical Sciences, Little Rock, AR | University of Arkansas for Medical Sciences/MIRT | University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy | UTMB/University of Arkansas